In mice, deficiency for the Irs2 gene produces MetS [6–8], and partial or total inactivation of Irs2 aggravates atheroma development in the apolipoprotein E-null (apoE−/−) mouse model of atherosclerosis [5, 9, 10]. Here, IRS2 is linked to metabolic syndrome.